Network origin in Takehiko Hamada first degree
Entity | Entity type | Industry | |
---|---|---|---|
SCOHIA PHARMA, Inc.
SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Takehiko Hamada via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Tokyo | College/University | Undergraduate Degree | |
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
CHIOME BIOSCIENCE INC. | Biotechnology | Director of Finance/CFO | |
Genetic Nosan Co., Ltd. | President | ||
Nimura Genetic Solutions Co., Ltd. | President | ||
GLOBIS University | College/University | Masters Business Admin | |
Nimura Genetic Solutions (M) Sdn. Bhd. | Director/Board Member | ||
Megakaryon Corp.
Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Medical/Nursing Services | Director/Board Member | |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Biotechnology | Director/Board Member | |
LivTech, Inc.
LivTech, Inc. Pharmaceuticals: OtherHealth Technology Part of Chiome Bioscience, Inc., LivTech, Inc. researches medicines. The company is based in Kawasaki, Japan. LivTech was acquired by Chiome Bioscience, Inc. on December 31, 2013. | Pharmaceuticals: Other | Director/Board Member |
Statistics
International
Japan | 10 |
Malaysia | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Operational
Director/Board Member | 11 |
President | 3 |
Director of Finance/CFO | 2 |
Chief Administrative Officer | 1 |
Investor Relations Contact | 1 |
Most connected contacts
Insiders | |
---|---|
Keiichi Kiyota | 6 |
Takehiko Sawabe | 6 |
Masanori Watanabe | 1 |
- Stock Market
- Insiders
- Takehiko Hamada
- Company connections